Nigeria’s pharmaceutical research sector has secured another major international breakthrough as two research abstracts developed by Nigerian community pharmacists were officially accepted for presentation at the prestigious 84th International Pharmaceutical Federation (FIP) World Congress of Pharmacy and Pharmaceutical Sciences in Montreal, Canada.
The acceptance places Nigeria on the global pharmaceutical research map ahead of the 2026 congress, widely regarded as the world’s largest gathering of pharmacy professionals, researchers, policymakers, and healthcare experts.
The breakthrough is being celebrated within the pharmaceutical sector as a strong international endorsement of Nigeria’s growing contributions to pharmacy practice, workforce development, and evidence-based healthcare reforms.
The accepted studies were developed under the Community Pharmacists Assessment and Career Progression Institute (CPACPI), a professional framework championed by the Association of Community Pharmacists of Nigeria (ACPN) to strengthen competency development and structured career progression among pharmacists.
Industry analysts described the development as a significant boost for Nigeria’s healthcare reputation and a sign that locally driven pharmaceutical initiatives are gaining increasing global relevance.
The development also follows the earlier international recognition of the CPACPI framework at a previous FIP Congress in Denmark, where the initiative gained adoption by the FIP Community Pharmacy Section.
One of the accepted research papers examines barriers affecting career advancement among Nigerian community pharmacists, including institutional, regulatory, and workforce challenges limiting professional growth and healthcare delivery.
The second study focuses on pharmacists who adopted the CPACPI framework during its early implementation phase, providing insights into changing professional standards and evolving community pharmacy practice in Nigeria.
Chairman of the CPACPI Board, Dr. Iyeseun Asieba, described the acceptance as proof that innovations emerging from Nigeria’s pharmaceutical sector can compete globally and contribute meaningfully to international healthcare discussions.
Also reacting, ACPN National Chairman, Pharm. Ambrose Ezeh, said the recognition reinforces the urgent need for structured professional development systems capable of strengthening pharmaceutical care and improving patient outcomes.
He added that the international exposure expected from the Montreal presentations could accelerate broader institutional support for healthcare reforms and competency-based pharmacy practice in Nigeria.
The accepted abstracts are expected to be presented before global pharmaceutical leaders, researchers, regulators, and healthcare stakeholders from across more than 100 countries during the congress.
Reporting By Niran Odufayo